About NGB Diagnostics
NGB Diagnostics is a company based in Delhi (India) by Rakesh Maurya. It operates as a B2B. NGB Diagnostics offers products and services including Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification. NGB Diagnostics operates in a competitive market with competitors including Abcam, Arbor Biotechnologies, Singleron, Stem Cell Technologies and Octant, among others.
- Headquarter Delhi, India
- Founders Rakesh Maurya
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ngb Diagnostics Private Limited
- Date of Incorporation 05 Jun, 2012
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$407.68 K (USD)-31.69as on Mar 31, 2023
-
Net Profit
$6.06 K (USD)-36.19as on Mar 31, 2023
-
EBITDA
$9.02 K (USD)-35.19as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NGB Diagnostics
NGB Diagnostics offers a comprehensive portfolio of products and services, including Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification.
Service for sequencing entire genomes for research.
Sequencing of exomes for targeted genetic analysis.
Analysis of RNA transcripts for gene expression studies.
Identification of proteins using advanced techniques.
Quantification method for proteomic profiling.
Funding Insights of NGB Diagnostics
Detailed funding history for NGB Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NGB Diagnostics
Investment portfolio details for NGB Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NGB Diagnostics
Detailed financials for NGB Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ngb Diagnostics Comparisons
Peer comparison for NGB Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NGB Diagnostics
NGB Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Arbor Biotechnologies, Singleron, Stem Cell Technologies and Octant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Genomic technologies and drug discovery platforms are provided.
|
|
| Locked | Locked | Locked |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Human cell interaction platform is provided for drug discovery.
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
Detailed competitors of NGB Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ngb Diagnostics
Complete news archive for NGB Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NGB Diagnostics
NGB Diagnostics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Rakesh Maurya is the current CEO of NGB Diagnostics. They have also founded this company.
Annual revenue of NGB Diagnostics is $407.68K as on Mar 31, 2023.
NGB Diagnostics Private Limited, founded in 2012, delivers high-quality genomics and proteomics services using advanced bioinformatic pipelines. They specialize in whole genome sequencing, RNA sequencing, and protein analysis for clinical diagnostics, pharmaceutical, RD, and agro-food sectors. Based in India, they focus on affordable solutions with certified laboratories and cater to clients in healthcare and biotechnology industries.
NGB Diagnostics's top competitors include Abcam, Arbor Biotechnologies and Meridian Bioscience.
NGB Diagnostics offers Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification.